nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—SV2A—telencephalon—malignant glioma	0.0352	0.121	CbGeAlD
Levetiracetam—Teratogenicity—Carmustine—malignant glioma	0.0323	0.0496	CcSEcCtD
Levetiracetam—Status epilepticus—Temozolomide—malignant glioma	0.0278	0.0426	CcSEcCtD
Levetiracetam—SV2A—medulla oblongata—malignant glioma	0.0277	0.0952	CbGeAlD
Levetiracetam—SV2A—midbrain—malignant glioma	0.0253	0.087	CbGeAlD
Levetiracetam—SV2A—spinal cord—malignant glioma	0.0247	0.0849	CbGeAlD
Levetiracetam—CACNA1B—telencephalon—malignant glioma	0.0243	0.0838	CbGeAlD
Levetiracetam—SV2A—cerebellum—malignant glioma	0.0196	0.0673	CbGeAlD
Levetiracetam—CACNA1B—medulla oblongata—malignant glioma	0.0191	0.0658	CbGeAlD
Levetiracetam—Abnormal behaviour—Temozolomide—malignant glioma	0.0176	0.027	CcSEcCtD
Levetiracetam—CACNA1B—midbrain—malignant glioma	0.0175	0.0602	CbGeAlD
Levetiracetam—CACNA1B—spinal cord—malignant glioma	0.017	0.0587	CbGeAlD
Levetiracetam—Paranoid reaction—Carmustine—malignant glioma	0.0159	0.0245	CcSEcCtD
Levetiracetam—SV2A—brain—malignant glioma	0.0159	0.0547	CbGeAlD
Levetiracetam—Personality disorder—Carmustine—malignant glioma	0.0157	0.024	CcSEcCtD
Levetiracetam—CACNA1B—central nervous system—malignant glioma	0.0138	0.0476	CbGeAlD
Levetiracetam—CACNA1B—cerebellum—malignant glioma	0.0135	0.0465	CbGeAlD
Levetiracetam—CACNA1B—brain—malignant glioma	0.011	0.0378	CbGeAlD
Levetiracetam—Tooth disorder—Temozolomide—malignant glioma	0.0101	0.0155	CcSEcCtD
Levetiracetam—Paranoia—Carmustine—malignant glioma	0.00994	0.0153	CcSEcCtD
Levetiracetam—CACNA1B—Synaptic Vesicle Pathway—SYP—malignant glioma	0.0097	0.167	CbGpPWpGaD
Levetiracetam—Apathy—Temozolomide—malignant glioma	0.00917	0.0141	CcSEcCtD
Levetiracetam—Flat affect—Temozolomide—malignant glioma	0.00908	0.0139	CcSEcCtD
Levetiracetam—Otitis media—Temozolomide—malignant glioma	0.00841	0.0129	CcSEcCtD
Levetiracetam—Memory impairment—Temozolomide—malignant glioma	0.00834	0.0128	CcSEcCtD
Levetiracetam—Accidental injury—Carmustine—malignant glioma	0.00766	0.0118	CcSEcCtD
Levetiracetam—Disturbance in attention—Temozolomide—malignant glioma	0.00756	0.0116	CcSEcCtD
Levetiracetam—Thinking abnormal—Carmustine—malignant glioma	0.0074	0.0114	CcSEcCtD
Levetiracetam—Drug interaction—Carmustine—malignant glioma	0.0073	0.0112	CcSEcCtD
Levetiracetam—Viral infection—Temozolomide—malignant glioma	0.00725	0.0111	CcSEcCtD
Levetiracetam—Gait disturbance—Carmustine—malignant glioma	0.00694	0.0107	CcSEcCtD
Levetiracetam—Coordination abnormal—Carmustine—malignant glioma	0.0069	0.0106	CcSEcCtD
Levetiracetam—Neck pain—Carmustine—malignant glioma	0.00686	0.0105	CcSEcCtD
Levetiracetam—Gait disturbance—Temozolomide—malignant glioma	0.00671	0.0103	CcSEcCtD
Levetiracetam—Coordination abnormal—Temozolomide—malignant glioma	0.00667	0.0102	CcSEcCtD
Levetiracetam—Respiratory failure—Temozolomide—malignant glioma	0.00667	0.0102	CcSEcCtD
Levetiracetam—Urinary incontinence—Carmustine—malignant glioma	0.00654	0.01	CcSEcCtD
Levetiracetam—Urinary incontinence—Temozolomide—malignant glioma	0.00632	0.0097	CcSEcCtD
Levetiracetam—Mental disability—Carmustine—malignant glioma	0.00588	0.00902	CcSEcCtD
Levetiracetam—ABCB1—blood vessel—malignant glioma	0.00584	0.0201	CbGeAlD
Levetiracetam—Mental disability—Temozolomide—malignant glioma	0.00568	0.00872	CcSEcCtD
Levetiracetam—Ear pain—Temozolomide—malignant glioma	0.00557	0.00855	CcSEcCtD
Levetiracetam—Gastroenteritis—Temozolomide—malignant glioma	0.00536	0.00823	CcSEcCtD
Levetiracetam—Injury—Carmustine—malignant glioma	0.00535	0.00821	CcSEcCtD
Levetiracetam—Hepatic failure—Temozolomide—malignant glioma	0.00529	0.00812	CcSEcCtD
Levetiracetam—Amnesia—Carmustine—malignant glioma	0.00524	0.00803	CcSEcCtD
Levetiracetam—Nasal congestion—Temozolomide—malignant glioma	0.00522	0.00801	CcSEcCtD
Levetiracetam—Amnesia—Temozolomide—malignant glioma	0.00506	0.00776	CcSEcCtD
Levetiracetam—Hyponatraemia—Carmustine—malignant glioma	0.00494	0.00758	CcSEcCtD
Levetiracetam—Diplopia—Carmustine—malignant glioma	0.00492	0.00755	CcSEcCtD
Levetiracetam—Diplopia—Temozolomide—malignant glioma	0.00475	0.00729	CcSEcCtD
Levetiracetam—Face oedema—Carmustine—malignant glioma	0.00475	0.00729	CcSEcCtD
Levetiracetam—Affect lability—Temozolomide—malignant glioma	0.00468	0.00718	CcSEcCtD
Levetiracetam—Ataxia—Carmustine—malignant glioma	0.00462	0.0071	CcSEcCtD
Levetiracetam—Face oedema—Temozolomide—malignant glioma	0.00459	0.00704	CcSEcCtD
Levetiracetam—Liver function test abnormal—Carmustine—malignant glioma	0.00454	0.00697	CcSEcCtD
Levetiracetam—Mood swings—Temozolomide—malignant glioma	0.0045	0.00691	CcSEcCtD
Levetiracetam—Ataxia—Temozolomide—malignant glioma	0.00447	0.00686	CcSEcCtD
Levetiracetam—Dehydration—Temozolomide—malignant glioma	0.00442	0.00678	CcSEcCtD
Levetiracetam—Muscular weakness—Carmustine—malignant glioma	0.00434	0.00666	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00428	0.00657	CcSEcCtD
Levetiracetam—Muscular weakness—Temozolomide—malignant glioma	0.00419	0.00643	CcSEcCtD
Levetiracetam—Pancytopenia—Carmustine—malignant glioma	0.00404	0.00619	CcSEcCtD
Levetiracetam—Neutropenia—Carmustine—malignant glioma	0.00398	0.0061	CcSEcCtD
Levetiracetam—Bronchitis—Temozolomide—malignant glioma	0.00395	0.00606	CcSEcCtD
Levetiracetam—Pancytopenia—Temozolomide—malignant glioma	0.0039	0.00599	CcSEcCtD
Levetiracetam—Neutropenia—Temozolomide—malignant glioma	0.00384	0.00589	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00382	0.00586	CcSEcCtD
Levetiracetam—Depression—Carmustine—malignant glioma	0.00378	0.0058	CcSEcCtD
Levetiracetam—Weight increased—Temozolomide—malignant glioma	0.00374	0.00574	CcSEcCtD
Levetiracetam—Weight decreased—Temozolomide—malignant glioma	0.00372	0.0057	CcSEcCtD
Levetiracetam—Stomatitis—Carmustine—malignant glioma	0.00369	0.00567	CcSEcCtD
Levetiracetam—Urinary tract infection—Carmustine—malignant glioma	0.00368	0.00565	CcSEcCtD
Levetiracetam—Infestation—Temozolomide—malignant glioma	0.00366	0.00562	CcSEcCtD
Levetiracetam—Infestation NOS—Temozolomide—malignant glioma	0.00366	0.00562	CcSEcCtD
Levetiracetam—Depression—Temozolomide—malignant glioma	0.00365	0.0056	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00363	0.00557	CcSEcCtD
Levetiracetam—Stomatitis—Temozolomide—malignant glioma	0.00357	0.00548	CcSEcCtD
Levetiracetam—Urinary tract infection—Temozolomide—malignant glioma	0.00356	0.00546	CcSEcCtD
Levetiracetam—ABCB1—embryo—malignant glioma	0.00348	0.012	CbGeAlD
Levetiracetam—Hepatobiliary disease—Temozolomide—malignant glioma	0.00346	0.00532	CcSEcCtD
Levetiracetam—Sinusitis—Temozolomide—malignant glioma	0.00344	0.00527	CcSEcCtD
Levetiracetam—Hallucination—Carmustine—malignant glioma	0.00339	0.0052	CcSEcCtD
Levetiracetam—Connective tissue disorder—Carmustine—malignant glioma	0.00334	0.00513	CcSEcCtD
Levetiracetam—Hepatitis—Temozolomide—malignant glioma	0.00329	0.00505	CcSEcCtD
Levetiracetam—Hallucination—Temozolomide—malignant glioma	0.00327	0.00502	CcSEcCtD
Levetiracetam—Pharyngitis—Temozolomide—malignant glioma	0.00326	0.00501	CcSEcCtD
Levetiracetam—Connective tissue disorder—Temozolomide—malignant glioma	0.00323	0.00496	CcSEcCtD
Levetiracetam—Eye disorder—Carmustine—malignant glioma	0.00318	0.00488	CcSEcCtD
Levetiracetam—Erythema multiforme—Temozolomide—malignant glioma	0.00311	0.00477	CcSEcCtD
Levetiracetam—ABCB1—retina—malignant glioma	0.00308	0.0106	CbGeAlD
Levetiracetam—Eye disorder—Temozolomide—malignant glioma	0.00307	0.00472	CcSEcCtD
Levetiracetam—Alopecia—Carmustine—malignant glioma	0.00301	0.00461	CcSEcCtD
Levetiracetam—Mental disorder—Carmustine—malignant glioma	0.00298	0.00457	CcSEcCtD
Levetiracetam—Immune system disorder—Temozolomide—malignant glioma	0.00297	0.00456	CcSEcCtD
Levetiracetam—Mediastinal disorder—Temozolomide—malignant glioma	0.00296	0.00455	CcSEcCtD
Levetiracetam—Malnutrition—Carmustine—malignant glioma	0.00296	0.00455	CcSEcCtD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—ATP1B2—malignant glioma	0.00293	0.0506	CbGpPWpGaD
Levetiracetam—Alopecia—Temozolomide—malignant glioma	0.00291	0.00446	CcSEcCtD
Levetiracetam—Mental disorder—Temozolomide—malignant glioma	0.00288	0.00442	CcSEcCtD
Levetiracetam—Back pain—Carmustine—malignant glioma	0.00287	0.0044	CcSEcCtD
Levetiracetam—Malnutrition—Temozolomide—malignant glioma	0.00286	0.00439	CcSEcCtD
Levetiracetam—ABCB1—telencephalon—malignant glioma	0.00283	0.00976	CbGeAlD
Levetiracetam—Vision blurred—Carmustine—malignant glioma	0.00279	0.00428	CcSEcCtD
Levetiracetam—Tremor—Carmustine—malignant glioma	0.00278	0.00426	CcSEcCtD
Levetiracetam—Back pain—Temozolomide—malignant glioma	0.00277	0.00425	CcSEcCtD
Levetiracetam—Agitation—Carmustine—malignant glioma	0.00272	0.00418	CcSEcCtD
Levetiracetam—Vision blurred—Temozolomide—malignant glioma	0.0027	0.00414	CcSEcCtD
Levetiracetam—Tremor—Temozolomide—malignant glioma	0.00268	0.00412	CcSEcCtD
Levetiracetam—Leukopenia—Carmustine—malignant glioma	0.00265	0.00407	CcSEcCtD
Levetiracetam—Agitation—Temozolomide—malignant glioma	0.00263	0.00404	CcSEcCtD
Levetiracetam—Vertigo—Temozolomide—malignant glioma	0.00257	0.00395	CcSEcCtD
Levetiracetam—Convulsion—Carmustine—malignant glioma	0.00257	0.00394	CcSEcCtD
Levetiracetam—Leukopenia—Temozolomide—malignant glioma	0.00256	0.00393	CcSEcCtD
Levetiracetam—Chest pain—Carmustine—malignant glioma	0.00252	0.00387	CcSEcCtD
Levetiracetam—Myalgia—Carmustine—malignant glioma	0.00252	0.00387	CcSEcCtD
Levetiracetam—Anxiety—Carmustine—malignant glioma	0.00251	0.00386	CcSEcCtD
Levetiracetam—Cough—Temozolomide—malignant glioma	0.0025	0.00383	CcSEcCtD
Levetiracetam—Convulsion—Temozolomide—malignant glioma	0.00248	0.00381	CcSEcCtD
Levetiracetam—Confusional state—Carmustine—malignant glioma	0.00244	0.00374	CcSEcCtD
Levetiracetam—Arthralgia—Temozolomide—malignant glioma	0.00244	0.00374	CcSEcCtD
Levetiracetam—Myalgia—Temozolomide—malignant glioma	0.00244	0.00374	CcSEcCtD
Levetiracetam—Anxiety—Temozolomide—malignant glioma	0.00243	0.00373	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00242	0.00371	CcSEcCtD
Levetiracetam—ABCC2—Irinotecan Pathway—BCHE—malignant glioma	0.00242	0.0417	CbGpPWpGaD
Levetiracetam—Infection—Carmustine—malignant glioma	0.0024	0.00369	CcSEcCtD
Levetiracetam—Thrombocytopenia—Carmustine—malignant glioma	0.00237	0.00363	CcSEcCtD
Levetiracetam—Confusional state—Temozolomide—malignant glioma	0.00236	0.00361	CcSEcCtD
Levetiracetam—Infection—Temozolomide—malignant glioma	0.00232	0.00356	CcSEcCtD
Levetiracetam—Anorexia—Carmustine—malignant glioma	0.0023	0.00354	CcSEcCtD
Levetiracetam—Nervous system disorder—Temozolomide—malignant glioma	0.00229	0.00352	CcSEcCtD
Levetiracetam—Thrombocytopenia—Temozolomide—malignant glioma	0.00229	0.00351	CcSEcCtD
Levetiracetam—Skin disorder—Temozolomide—malignant glioma	0.00227	0.00348	CcSEcCtD
Levetiracetam—Anorexia—Temozolomide—malignant glioma	0.00223	0.00342	CcSEcCtD
Levetiracetam—ABCB1—medulla oblongata—malignant glioma	0.00223	0.00767	CbGeAlD
Levetiracetam—Musculoskeletal discomfort—Carmustine—malignant glioma	0.0022	0.00338	CcSEcCtD
Levetiracetam—Insomnia—Carmustine—malignant glioma	0.00219	0.00336	CcSEcCtD
Levetiracetam—Paraesthesia—Carmustine—malignant glioma	0.00217	0.00333	CcSEcCtD
Levetiracetam—Somnolence—Carmustine—malignant glioma	0.00215	0.0033	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00213	0.00327	CcSEcCtD
Levetiracetam—Insomnia—Temozolomide—malignant glioma	0.00211	0.00324	CcSEcCtD
Levetiracetam—Decreased appetite—Carmustine—malignant glioma	0.0021	0.00322	CcSEcCtD
Levetiracetam—Paraesthesia—Temozolomide—malignant glioma	0.0021	0.00322	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Carmustine—malignant glioma	0.00209	0.0032	CcSEcCtD
Levetiracetam—Somnolence—Temozolomide—malignant glioma	0.00208	0.00319	CcSEcCtD
Levetiracetam—Pain—Carmustine—malignant glioma	0.00207	0.00317	CcSEcCtD
Levetiracetam—Constipation—Carmustine—malignant glioma	0.00207	0.00317	CcSEcCtD
Levetiracetam—Dyspepsia—Temozolomide—malignant glioma	0.00206	0.00316	CcSEcCtD
Levetiracetam—ABCC2—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00204	0.0352	CbGpPWpGaD
Levetiracetam—ABCB1—midbrain—malignant glioma	0.00203	0.00701	CbGeAlD
Levetiracetam—Decreased appetite—Temozolomide—malignant glioma	0.00203	0.00312	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00202	0.00309	CcSEcCtD
Levetiracetam—Fatigue—Temozolomide—malignant glioma	0.00201	0.00309	CcSEcCtD
Levetiracetam—Constipation—Temozolomide—malignant glioma	0.002	0.00307	CcSEcCtD
Levetiracetam—Pain—Temozolomide—malignant glioma	0.002	0.00307	CcSEcCtD
Levetiracetam—Feeling abnormal—Carmustine—malignant glioma	0.00199	0.00306	CcSEcCtD
Levetiracetam—ABCB1—spinal cord—malignant glioma	0.00198	0.00684	CbGeAlD
Levetiracetam—Gastrointestinal pain—Carmustine—malignant glioma	0.00198	0.00303	CcSEcCtD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00194	0.0336	CbGpPWpGaD
Levetiracetam—Feeling abnormal—Temozolomide—malignant glioma	0.00193	0.00295	CcSEcCtD
Levetiracetam—Body temperature increased—Carmustine—malignant glioma	0.00191	0.00293	CcSEcCtD
Levetiracetam—Abdominal pain—Carmustine—malignant glioma	0.00191	0.00293	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Temozolomide—malignant glioma	0.00191	0.00293	CcSEcCtD
Levetiracetam—Body temperature increased—Temozolomide—malignant glioma	0.00185	0.00283	CcSEcCtD
Levetiracetam—Abdominal pain—Temozolomide—malignant glioma	0.00185	0.00283	CcSEcCtD
Levetiracetam—Hypersensitivity—Carmustine—malignant glioma	0.00178	0.00273	CcSEcCtD
Levetiracetam—Asthenia—Carmustine—malignant glioma	0.00173	0.00266	CcSEcCtD
Levetiracetam—Hypersensitivity—Temozolomide—malignant glioma	0.00172	0.00264	CcSEcCtD
Levetiracetam—Asthenia—Temozolomide—malignant glioma	0.00168	0.00257	CcSEcCtD
Levetiracetam—Diarrhoea—Carmustine—malignant glioma	0.00165	0.00254	CcSEcCtD
Levetiracetam—Pruritus—Temozolomide—malignant glioma	0.00165	0.00254	CcSEcCtD
Levetiracetam—ABCB1—central nervous system—malignant glioma	0.00161	0.00554	CbGeAlD
Levetiracetam—Dizziness—Carmustine—malignant glioma	0.0016	0.00245	CcSEcCtD
Levetiracetam—Diarrhoea—Temozolomide—malignant glioma	0.0016	0.00245	CcSEcCtD
Levetiracetam—ABCB1—cerebellum—malignant glioma	0.00157	0.00542	CbGeAlD
Levetiracetam—Dizziness—Temozolomide—malignant glioma	0.00154	0.00237	CcSEcCtD
Levetiracetam—Vomiting—Carmustine—malignant glioma	0.00154	0.00236	CcSEcCtD
Levetiracetam—Rash—Carmustine—malignant glioma	0.00152	0.00234	CcSEcCtD
Levetiracetam—Dermatitis—Carmustine—malignant glioma	0.00152	0.00234	CcSEcCtD
Levetiracetam—Headache—Carmustine—malignant glioma	0.00151	0.00232	CcSEcCtD
Levetiracetam—Vomiting—Temozolomide—malignant glioma	0.00149	0.00228	CcSEcCtD
Levetiracetam—Rash—Temozolomide—malignant glioma	0.00147	0.00226	CcSEcCtD
Levetiracetam—Dermatitis—Temozolomide—malignant glioma	0.00147	0.00226	CcSEcCtD
Levetiracetam—Headache—Temozolomide—malignant glioma	0.00146	0.00225	CcSEcCtD
Levetiracetam—Nausea—Carmustine—malignant glioma	0.00144	0.0022	CcSEcCtD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—YWHAE—malignant glioma	0.00139	0.024	CbGpPWpGaD
Levetiracetam—Nausea—Temozolomide—malignant glioma	0.00139	0.00213	CcSEcCtD
Levetiracetam—ABCC2—Irinotecan Pathway—APC—malignant glioma	0.00131	0.0226	CbGpPWpGaD
Levetiracetam—ABCB1—brain—malignant glioma	0.00128	0.0044	CbGeAlD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—GJA1—malignant glioma	0.00114	0.0198	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—BCHE—malignant glioma	0.00107	0.0185	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.00101	0.0174	CbGpPWpGaD
Levetiracetam—ABCB1—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000959	0.0166	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—FTH1—malignant glioma	0.000915	0.0158	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000914	0.0158	CbGpPWpGaD
Levetiracetam—SV2A—Disease—BCAN—malignant glioma	0.000864	0.0149	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PIM1—malignant glioma	0.000853	0.0147	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—BCHE—malignant glioma	0.000821	0.0142	CbGpPWpGaD
Levetiracetam—SV2A—Disease—DTX1—malignant glioma	0.000781	0.0135	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—SLC6A3—malignant glioma	0.000772	0.0133	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000622	0.0107	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HEY2—malignant glioma	0.000613	0.0106	CbGpPWpGaD
Levetiracetam—SV2A—Disease—IDH1—malignant glioma	0.000599	0.0103	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—NDRG1—malignant glioma	0.000572	0.00987	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HEY1—malignant glioma	0.000567	0.0098	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HIST1H3B—malignant glioma	0.000551	0.00952	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000547	0.00945	CbGpPWpGaD
Levetiracetam—SV2A—Disease—JAG2—malignant glioma	0.000503	0.00869	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—GDNF—malignant glioma	0.000495	0.00855	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000458	0.00791	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000457	0.00789	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL12A—malignant glioma	0.000453	0.00782	CbGpPWpGaD
Levetiracetam—SV2A—Disease—H3F3A—malignant glioma	0.000426	0.00735	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—malignant glioma	0.000426	0.00735	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—BRAF—malignant glioma	0.000419	0.00724	CbGpPWpGaD
Levetiracetam—SV2A—Disease—JAG1—malignant glioma	0.000402	0.00693	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FBXW7—malignant glioma	0.000393	0.00679	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—SLC5A5—malignant glioma	0.000366	0.00631	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—TFRC—malignant glioma	0.000353	0.0061	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—MDM2—malignant glioma	0.000351	0.00606	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—RAF1—malignant glioma	0.00035	0.00604	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—SLC6A3—malignant glioma	0.000348	0.00601	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—HLA-C—malignant glioma	0.000335	0.00578	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00032	0.00553	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CDKN2B—malignant glioma	0.000308	0.00532	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—GSTP1—malignant glioma	0.000294	0.00508	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HES1—malignant glioma	0.000294	0.00508	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000293	0.00506	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000293	0.00505	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NCOR1—malignant glioma	0.000292	0.00505	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	0.000292	0.00504	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL12B—malignant glioma	0.000284	0.00491	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PDGFRA—malignant glioma	0.00028	0.00483	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000258	0.00445	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HLA-A—malignant glioma	0.000258	0.00445	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TERT—malignant glioma	0.000258	0.00445	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000256	0.00442	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PDGFB—malignant glioma	0.000251	0.00434	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FGFR1—malignant glioma	0.00025	0.00432	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—APOD—malignant glioma	0.000249	0.0043	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HIF1A—malignant glioma	0.000246	0.00425	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CAV1—malignant glioma	0.000238	0.00411	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—PDGFB—malignant glioma	0.000233	0.00402	CbGpPWpGaD
Levetiracetam—SV2A—Disease—BAD—malignant glioma	0.000224	0.00387	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOTCH1—malignant glioma	0.000222	0.00383	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CD80—malignant glioma	0.000217	0.00375	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APC—malignant glioma	0.000217	0.00375	CbGpPWpGaD
Levetiracetam—SV2A—Disease—EGF—malignant glioma	0.000215	0.0037	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTPN11—malignant glioma	0.000213	0.00368	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.000212	0.00365	CbGpPWpGaD
Levetiracetam—SV2A—Disease—BRAF—malignant glioma	0.000204	0.00352	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	0.000202	0.00349	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—PDGFRA—malignant glioma	0.000199	0.00344	CbGpPWpGaD
Levetiracetam—SV2A—Disease—AKT2—malignant glioma	0.000199	0.00343	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—HLA-B—malignant glioma	0.000198	0.00342	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000195	0.00337	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIK3CD—malignant glioma	0.000191	0.00329	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000185	0.0032	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—HLA-A—malignant glioma	0.000183	0.00316	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FGF2—malignant glioma	0.000183	0.00315	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MDM2—malignant glioma	0.000171	0.00295	CbGpPWpGaD
Levetiracetam—SV2A—Disease—RAF1—malignant glioma	0.00017	0.00294	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ERBB2—malignant glioma	0.000169	0.00291	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIK3CB—malignant glioma	0.000166	0.00287	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000165	0.00285	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTGS2—malignant glioma	0.000165	0.00285	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CD80—malignant glioma	0.000155	0.00267	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000151	0.00261	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000151	0.0026	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTEN—malignant glioma	0.000144	0.00248	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000138	0.00238	CbGpPWpGaD
Levetiracetam—SV2A—Disease—STAT3—malignant glioma	0.000129	0.00222	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000128	0.0022	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.000125	0.00215	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—RTEL1—malignant glioma	0.000123	0.00212	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IFNG—malignant glioma	0.000122	0.00211	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00012	0.00208	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MYC—malignant glioma	0.000119	0.00206	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000117	0.00203	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000117	0.00202	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000117	0.00202	CbGpPWpGaD
Levetiracetam—SV2A—Disease—EGFR—malignant glioma	0.000117	0.00202	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CXCL8—malignant glioma	0.000114	0.00196	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000111	0.00192	CbGpPWpGaD
Levetiracetam—SV2A—Disease—KRAS—malignant glioma	0.00011	0.00191	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000109	0.00188	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL1B—malignant glioma	0.000109	0.00188	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CASP3—malignant glioma	0.000109	0.00188	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL2—malignant glioma	0.000109	0.00188	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000108	0.00187	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000107	0.00184	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIK3CA—malignant glioma	0.000101	0.00175	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	9.83e-05	0.0017	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—VEGFA—malignant glioma	9.24e-05	0.00159	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	8.78e-05	0.00152	CbGpPWpGaD
Levetiracetam—SV2A—Disease—AKT1—malignant glioma	8.28e-05	0.00143	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TNF—malignant glioma	7.92e-05	0.00137	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	7.87e-05	0.00136	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	7.62e-05	0.00132	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	7.53e-05	0.0013	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—COX8A—malignant glioma	7.05e-05	0.00122	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	6.8e-05	0.00117	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	6.41e-05	0.00111	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	6.09e-05	0.00105	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	6e-05	0.00104	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ASMT—malignant glioma	6e-05	0.00104	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	5.99e-05	0.00103	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	5.98e-05	0.00103	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	5.92e-05	0.00102	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	5.79e-05	0.000999	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—BCAN—malignant glioma	5.64e-05	0.000973	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	5.51e-05	0.00095	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	5.37e-05	0.000927	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	5.24e-05	0.000905	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—RAF1—malignant glioma	5.05e-05	0.000872	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	5.05e-05	0.000871	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	4.56e-05	0.000787	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—IDH2—malignant glioma	4.54e-05	0.000785	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2B6—malignant glioma	4.27e-05	0.000738	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	4.19e-05	0.000724	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	4.1e-05	0.000708	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—IDH1—malignant glioma	3.91e-05	0.000675	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.91e-05	0.000674	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.87e-05	0.000669	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SPHK1—malignant glioma	3.78e-05	0.000653	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2C18—malignant glioma	3.7e-05	0.00064	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.56e-05	0.000615	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.44e-05	0.000595	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTT1—malignant glioma	3e-05	0.000517	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.91e-05	0.000502	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGS1—malignant glioma	2.81e-05	0.000485	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—BCHE—malignant glioma	2.61e-05	0.000451	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC5A5—malignant glioma	2.58e-05	0.000445	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.37e-05	0.00041	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTP1—malignant glioma	2.08e-05	0.000359	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CAT—malignant glioma	2.02e-05	0.000349	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NCOR1—malignant glioma	1.91e-05	0.000329	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CAV1—malignant glioma	1.56e-05	0.000269	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CG—malignant glioma	1.42e-05	0.000245	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPARG—malignant glioma	1.37e-05	0.000236	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CD—malignant glioma	1.25e-05	0.000215	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CB—malignant glioma	1.09e-05	0.000187	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGS2—malignant glioma	1.08e-05	0.000186	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTEN—malignant glioma	9.38e-06	0.000162	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CA—malignant glioma	6.62e-06	0.000114	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AKT1—malignant glioma	5.41e-06	9.34e-05	CbGpPWpGaD
